# Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)

Study · id `cardio:ct-nct03096613` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03096613](<https://clinicaltrials.gov/study/NCT03096613>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03096613

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 124 participants.

## Technical summary

Registry record NCT03096613. Randomized; no masking; primary purpose treatment. Start 2017-04-18 (actual); primary completion 2019-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 124 participants (planned count; ClinicalTrials.gov record NCT03096613, source copy `cardio:ctgov-nct03096613-2018-03-29`, retrieved 2026-10-26)
- Started: 2017-04-18 (actual) (ClinicalTrials.gov record NCT03096613, source copy `cardio:ctgov-nct03096613-2018-03-29`, retrieved 2026-10-26)
- Primary completion: 2019-02 (anticipated) (ClinicalTrials.gov record NCT03096613, source copy `cardio:ctgov-nct03096613-2018-03-29`, retrieved 2026-10-26)
- Completion: 2019-02 (anticipated) (ClinicalTrials.gov record NCT03096613, source copy `cardio:ctgov-nct03096613-2018-03-29`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03096613, source copy `cardio:ctgov-nct03096613-2018-03-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03096613-2018-03-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)
- Condition: Heart Failure
- Condition: Subclinical Hypothyroidism
- Intervention (Drug): Levothyroxine
- Lead sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
- Lead sponsor class: OTHER
- Collaborator: The Luhe Teaching Hospital of the Capital Medical University
- Collaborator class: OTHER
- Collaborator: Tianjin Medical University Second Hospital
- Collaborator class: OTHER
- Collaborator: The First Hospital of Hebei Medical University
- Collaborator class: OTHER
- Collaborator: Henan Provincial People's Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital (`cardio:org-chinese-academy-of-medical-sciences-fuwai-hospital`)
- Registry lists this organization as a collaborator: The Luhe Teaching Hospital of the Capital Medical University (`cardio:org-the-luhe-teaching-hospital-of-the-capital-medical-university`)
- Registry lists this organization as a collaborator: The First Hospital of Hebei Medical University (`cardio:org-the-first-hospital-of-hebei-medical-university`)
- Registry lists this organization as a collaborator: Henan Provincial People's Hospital (`cardio:org-henan-provincial-people-s-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of levothyroxine in subclinical hypothyroidism and heart failure with reduced ejection fraction: An open-label randomized trial (`cardio:pubmed-38537636`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 8dc6862771701b22908dc659fcbf58b415feba4d4c5826beba4cecfc6058d8d6
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
